{
    "RADCURE-0665": {
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "question": "Age: 84.0, Sex: Female, ECOG PS: ECOG 2, Smoking PY: 5, Smoking Status: Ex-smoker, Ds Site: Oropharynx, Subsite: Tonsil, T: T3, N: N3, M : M0, Stage: IVB, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "initial_assessment-radiation oncologist": "Step-by-step analysis:\n\n1. The CT scan is a head and neck image with two provided bounding boxes:\n   - Box 1: [234, 153, 89, 234, 187, 113]\n   - Box 2: [251, 197, 118, 251, 230, 145]\n\n2. The bounding boxes are normalized coordinates relative to the image size, defining specific volumetric regions.\n\n3. From a radiation oncology perspective, these bounding boxes likely correspond to regions of interest such as tumor volumes or involved lymph nodes.\n\n4. The first bounding box appears to be located in a region consistent with the oropharynx or adjacent soft tissues, possibly representing a primary tumor or involved lymph node.\n\n5. The second bounding box is located more inferiorly and posteriorly, possibly corresponding to a nodal region in the neck.\n\n6. No direct visualization of gross anatomical abnormalities is possible here without the original image, but the presence of these ROIs suggests areas targeted for radiation therapy.\n\n7. Given the location and typical patterns of spread in head and neck squamous cell carcinoma, these ROIs may represent primary tumor and nodal disease.\n\n8. From a radiation oncologist's perspective, the presence of multiple involved regions (primary and nodal) may indicate advanced locoregional disease, which can impact survival probability.\n\n9. Without additional clinical data (tumor stage, HPV status, treatment details), precise survival prediction is limited.\n\nFinal answer:\nAnswer:Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no  \nAlive",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: HPV+ oropharynx cases under radiation scope covered\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}